BioXcel Therapeutics, Inc. (BTAI)
1.55
-0.02
(-1.27%)
USD |
NASDAQ |
Mar 12, 16:00
1.56
+0.01
(+0.65%)
Pre-Market: 08:31
BioXcel Therapeutics EPS Diluted (Quarterly) : -2.177 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Rigel Pharmaceuticals, Inc. | 13.54 |
| Puma Biotechnology, Inc. | 0.2608 |
| Quince Therapeutics, Inc. | -0.2492 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -30.91M |
| Revenue (Quarterly) | 0.098M |
| Total Expenses (Quarterly) | 31.01M |
| Enterprise Value | 105.86M |
| Gross Profit Margin (Quarterly) | 12.24% |
| Profit Margin (Quarterly) | -31.54K% |
| Earnings Yield | -625.7% |
| Normalized Earnings Yield | -570.21 |